Zobrazeno 1 - 10
of 115
pro vyhledávání: '"D. D. Ivanov"'
Autor:
S. V. Kushnirenko, D. D. Ivanov
Publikováno v:
Сучасна педіатрія: Україна, Iss 8(104), Pp 41-47 (2019)
Мета: оцінити вплив 5-річної ренопротекторної терапії на сповільнення прогресування хронічної хвороби нирок (ХХН) у дітей з вродженими в
Externí odkaz:
https://doaj.org/article/a17ba0e106ae4f64b2286172c928c6bc
Publikováno v:
Počki, Vol 7, Iss 3, Pp 211-216 (2018)
Externí odkaz:
https://doaj.org/article/9db3c4a0d6f84da2beccc57dcc2538eb
Autor:
D. D. Ivanov
Publikováno v:
Počki, Vol 6, Iss 4 (2017)
Externí odkaz:
https://doaj.org/article/6677ef36d3254567afccfb1d8a754d47
Autor:
A. I. Gozhenko, D. D. Ivanov
Publikováno v:
Nephrology (Saint-Petersburg). 26:102-109
The presented material raises the most important question in practical nephrology – how to correctly assess kidney function to understand the prognosis and duration of the predialysis period in a particular patient with chronic kidney disease (CKD)
Autor:
D. D. Ivanov, A. E. Teretenkov
Publikováno v:
Mathematical Notes. 112:318-322
Publikováno v:
Nephrology (Saint-Petersburg). 26:34-43
BACKGROUND. The presence and drug correction of arterial hypertension (AH) with inhibitors of the renin-angiotensin system (RAS), as well as chronic kidney disease (CKD) and its role in the regulation of RAS, can significantly affect the condition of
Autor:
T. N. Tolstykh, E. N. Misyurina, M. A. Mingalimov, E. A. Baryakh, E. I. Zhelnova, D. E. Gagloeva, S. A. Kardovskaya, T. S. Chudnova, E. N. Zotina, D. D. Ivanova, O. L. Kochneva, K. V. Yatskov, L. T. Shimanovskaya, D. S. Mar’in, A. B. Makeshova, N. G. Chernova, G. A. Dudina, M. A. Granatkin, T. A. Semina, A. V. Misyurin, M. A. Lysenko
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 99-111 (2024)
Aim. To evaluate the acute myeloid leukemia (AML) treatment efficacy in adults in Moscow real clinical practice according to the Moscow Cancer Registry data.Materials and methods. We retrospectively collected data from the Moscow Cancer Registry on M
Externí odkaz:
https://doaj.org/article/7f315582fe1a4a3cb87996f49a846926
Autor:
T. S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, V. N. Yakimets
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 206-214 (2024)
Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19 throughout the coronavirus pandemic. Secondary immunodeficiency due to acute leukemia, as wel
Externí odkaz:
https://doaj.org/article/84e5c35a50cc4b5eade5ae9d63731241
Publikováno v:
Matematicheskie Zametki. 112:307-311
Publikováno v:
KIDNEYS. 7:211-216